Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo Sézary syndrome patient tumor cells are sensitive to ATR inhibition.

The Journal of investigative dermatology·2026
Same author

How We Evaluate and Treat Leukemic Presentations of Mature T-Cell Lymphomas.

Cancers·2026
Same author

Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome.

British journal of haematology·2025
Same author

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.

Blood·2025
Same author

Syringotropic mycosis fungoides with clinical and histologic features of necrobiosis lipoidica diabeticorum.

JAAD case reports·2025
Same author

Atypical bullous systemic lupus erythematosus with features of linear IgA bullous dermatosis.

JAAD case reports·2025

Related Experiment Video

Updated: Jul 8, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Nephrogenic systemic fibrosis: a dermatologist's perspective.

Michael Girardi1

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520-8042, USA. girardi@yale.edu

Journal of the American College of Radiology : JACR
|January 9, 2008
PubMed
Summary

Nephrogenic systemic fibrosis can cause various skin lesions, from subtle papules to severe joint contractures. Early recognition aids diagnosis and understanding of this condition.

Related Experiment Videos

Last Updated: Jul 8, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Area of Science:

  • Dermatology
  • Nephrology
  • Pathology

Background:

  • Nephrogenic systemic fibrosis (NSF) is a serious condition linked to gadolinium-based contrast agents.
  • NSF commonly presents with characteristic skin manifestations, impacting patient diagnosis and prognosis.

Purpose of the Study:

  • To review the cutaneous manifestations of NSF from a dermatologist's viewpoint.
  • To discuss the differential diagnosis of NSF-related skin lesions.
  • To explore potential therapeutic options for NSF skin conditions.

Main Methods:

  • Literature review of dermatological presentations of NSF.
  • Comparative analysis of NSF skin findings with similar dermatological conditions.
  • Discussion of treatment modalities, including extracorporeal photopheresis.

Main Results:

  • NSF presents with a spectrum of skin lesions, including papules, plaques, induration, and joint contractures.
  • Accurate recognition of these lesions is crucial for diagnosing NSF.
  • Understanding the differential diagnosis aids in confirming NSF and elucidating its pathogenesis.

Conclusions:

  • Cutaneous manifestations are key indicators of nephrogenic systemic fibrosis.
  • Dermatological assessment is vital for early NSF diagnosis and management.
  • Extracorporeal photopheresis shows potential as a treatment for NSF-induced skin changes.